We have located links that may give you full text access.
Fusion of Quantitative Imaging Features and Serum Biomarkers to Improve Performance of Computer-aided Diagnosis Scheme for Lung Cancer: A Preliminary Study.
Medical Physics 2018 October 14
OBJECTIVES: To develop and test a new multi-feature based computer-aided diagnosis (CADx) scheme of lung cancer by fusing quantitative imaging (QI) features and serum biomarkers to improve CADx performance in classifying between malignant and benign pulmonary nodules.
METHODS: First, a dataset involving 173 patients was retrospectively assembled, which includes computed tomography (CT) images and five serum biomarkers extracted from blood samples. Second, a CADx scheme using a four-step based semiautomatic segmentation method was applied to segment the targeted lung nodules, and compute 78 QI features from each segmented nodule from CT images. Third, two support vector machine (SVM) classifiers were built using QI features and serum biomarkers, respectively. SVM classifiers were trained and tested using the overall dataset with a Relief feature selection method, a synthetic minority over-sampling technique and a leave-one-case-out validation method. Finally, to further improve CADx performance, an information-fusion method was used to combine the prediction scores generated by two SVM classifiers.
RESULTS: Areas under receiver operating characteristic curves (AUC) generated by QI feature and serum biomarker based SVMs were 0.81±0.03 and 0.69±0.05, respectively. Using an optimal weighted fusion method to combine prediction scores generated by two SVMs, AUC value significantly increased to 0.85±0.03 (p < 0.05).
CONCLUSIONS: This study demonstrates (1) higher CADx performance by using QI features than using the serum biomarkers and (2) feasibility of further improving CADx performance by fusion of QI features and serum biomarkers, which indicates that QI features and serum biomarkers contain the complementary classification information. This article is protected by copyright. All rights reserved.
METHODS: First, a dataset involving 173 patients was retrospectively assembled, which includes computed tomography (CT) images and five serum biomarkers extracted from blood samples. Second, a CADx scheme using a four-step based semiautomatic segmentation method was applied to segment the targeted lung nodules, and compute 78 QI features from each segmented nodule from CT images. Third, two support vector machine (SVM) classifiers were built using QI features and serum biomarkers, respectively. SVM classifiers were trained and tested using the overall dataset with a Relief feature selection method, a synthetic minority over-sampling technique and a leave-one-case-out validation method. Finally, to further improve CADx performance, an information-fusion method was used to combine the prediction scores generated by two SVM classifiers.
RESULTS: Areas under receiver operating characteristic curves (AUC) generated by QI feature and serum biomarker based SVMs were 0.81±0.03 and 0.69±0.05, respectively. Using an optimal weighted fusion method to combine prediction scores generated by two SVMs, AUC value significantly increased to 0.85±0.03 (p < 0.05).
CONCLUSIONS: This study demonstrates (1) higher CADx performance by using QI features than using the serum biomarkers and (2) feasibility of further improving CADx performance by fusion of QI features and serum biomarkers, which indicates that QI features and serum biomarkers contain the complementary classification information. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app